India is entering into Human trial of Covid-19 vaccine.

HIGHLIGHTS –

• Over 140 candidates are in race to make Covid-19 Vaccine are under different development stages.
• 60% of vaccines are manufactured by India.
• India stands in position three after beating Russia on corona virus cases.

Two covid-19 vaccine COVAXIN by Bharat Biotech international limited with ICMR and NIV and ZyCov-D vaccine by Zydus cadila had recently got green signal for human trials from DCGI ( Drug controller general of India ) . Both are up for phase II and phase III trials.

" The nod given by Drug controller General of India CDSCO ( The central drugs standard control organisation ) for the conduct of human trials for the vaccine, 'marks the beginning of the end', written in a letter by Ministry of science and technology.

Over 140 candidate to make vaccine, only 11 candidate entered the human trial phase including the two Indian vaccine candidates.

"Both these forms have already inked an agreement with India manufacturer for production of covid vaccines ", government said.

" In the past years, India has emerged as one of the significant vaccine manufacturing hub. Indian manufacturers account for 60% of vaccine supplies made to UNICEF. The vaccine for novel coronavirus may be developed anywhere in the world, but without Indian manufactures involved the production of required quantity is going to be feasible", says Ministry.

With more than 24,248 new cases, India has now took over Russia covid cases . India climbs up to third position in covid-19 cases in world ranking .

ALSO READ -